Munro Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Munro Partners's LLY Position: Q2 2026 in Review
Munro Partners reduced its Eli Lilly (LLY) stake by 4.7% in Q2 2026, selling an estimated $4.94M and leaving 97,240 shares worth $117M. The position accounts for 2.57% of the portfolio, ranked #14.
Munro Partners first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Munro Partners held 97,240 shares of Eli Lilly worth $117M as of Q2 2026.
- Munro Partners sold 4,835 Eli Lilly shares in Q2 2026, an estimated $4.94M.
- Eli Lilly made up 2.57% of Munro Partners's portfolio in Q2 2026, its #14 holding.
- Munro Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Munro Partners's 13F filing for Q2 2026, filed 10 Aug 2026.